First subject dosed in psilocybin trial for rare headache disorderThe first patient has received a low dose of Beckley Psytech’s psychedelic medicine psilocybin in a clinical trial Share XFirst subject dosed in psilocybin trial for rare headache disorderhttps://pharmaphorum.com/news/first-subject-dosed-in-psilocybin-trial-for-rare-headache-disorder/
Beckley Psytech raises $80m for psychedelic meds developmentUK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed Share XBeckley Psytech raises $80m for psychedelic meds developmenthttps://pharmaphorum.com/news/beckley-psytech-raises-80m-for-psychedelic-meds-development/
